Your Search Results

Rapid-fire - Complex procedure in TAVI - Part 2

18 Feb 2024 – From PCR Tokyo Valves 2024

In the second part of this rapid-fire session, we continue to focus on complex cases that might arise during TAVI, such as a case of prosthetic aortic valve endocarditis resulting in cardiogenic shock, treatment of severe AR after infective endocarditis, and more!

Rapid-fire - Complications of Mitral TEER - Part 2

18 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the possible complications of Mitral Transcatheter Edge-to-Edge Repair (TEER) in the second part of this session rapid-fire submission cases [in Japanese].

Nightmares in TAVI: sharing solutions together

18 Feb 2024 – From PCR Tokyo Valves 2024

Consult this session to learn more about bailout techniques for TAVI during uncommon complications, such as late coronary obstruction post-TAVI, a migrated self-expandable valve, or a C-tab induced iatrogenic thoracic aortic dissection after Evolut FX implantation.

Imaging for aortic valve disease

18 Feb 2024 – From PCR Tokyo Valves 2024

Learn about imaging of the aortic valve system in order to better deal with aortic valve disease. Through this series of cases, explore topics such as the impact of implantation depth relative to membranous septum on TAVI outcomes, delve into a meta-analysis exploring the outcomes of...

Ticagrelor vs Clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome

15 Mar 2024

The results of this sub-analysis of the ALPHEUS trial show that complex PCI criteria are present in a large percentage of patients with chronic coronary syndrome and are associated with higher rates of both periprocedural events and MACE than non-complex PCI.

Reviewer

Sylwia Iwanczyk

Reviewer

Nicola Ryan

Ticagrelor vs Clopidogrel for complex PCI in chronic coronary syndrome

Louis Verdier

Toulouse, France

Non–vitamin K antagonist versus vitamin K antagonist oral anticoagulant agents after transcatheter aortic valve replacement

19 Mar 2024

This study demonstrates that, at 5 years post TAVI in patients with an indication for OAC, the net clinical benefit did not differ between the VKA and DOAC groups.

Reviewer

Nicola Ryan

Reviewer

Aleksandra Gasecka

Non–vitamin K antagonist vs vitamin K antagonist oral anticoagulant agents after TAVR

Rapid-fire - Bailout in SHD

17 Feb 2024 – From PCR Tokyo Valves 2024

Gain valuable insights into the bailout techniques in structural heart disease intervention in this session of rapid-fire submission cases (in Japanese).

Coronary vasomotor dysfunction is associated with cardiovascular events in patients with nonobstructive coronary artery disease

29 Mar 2024

In this large single centre registry investigators demonstrated that with the exception of endothelium independent epicardial coronary artery dysfunction, CVDys diagnosed by interventional functional assessment is correlated with adverse cardiac and cerebrovascular events.

Reviewer

Leonidas Koliastasis

Reviewer

Nicola Ryan

Coronary vasomotor dysfunction is associated with cardiovascular events in patients with nonobstructive coronary artery disease

MitraClip sets a new standard for TEER therapy based on the EXPAND G4 data in Japan

20 Mar 2024 – From PCR Tokyo Valves 2024

This video discusses the results of the Expand G4 trial conducted in Japan, focusing on the use of MitraClip for transcatheter edge-to-edge repair therapy. Interviewed by Mike Saji, Masahiko Asami presents data showing a high success rate in Japanese patients, with significant reductions in mitral regurgitation...

Advanced course on transseptal puncture - Registration in Milan

21 Mar 2024

Check out what's included in the package!

⚠️ Registration alert: Please use our official platform to register for the Advanced Course on Transseptal Puncture. PCR Course organisers cannot be held responsible for any issue encountered when using third-party websites.

Quantitative coronary angiography vs intravascular ultrasonography to guide drug-eluting stent implantation - a randomized clinical trial

21 Mar 2024

The trial aimed to establish the non-inferiority of QCA-guided PCI compared to IVUS-guided PCI with respect to the primary endpoint of TLF at 12 months, defined as a composite of cardiac death, target vessel MI, or ischemia-driven target lesion revascularization.